745 related articles for article (PubMed ID: 18269675)
1. From allergen genes to new forms of allergy diagnosis and treatment.
Vrtala S
Allergy; 2008 Mar; 63(3):299-309. PubMed ID: 18269675
[TBL] [Abstract][Full Text] [Related]
2. Genetically engineered and synthetic allergen derivatives: candidates for vaccination against type I allergy.
Valenta R; Vrtala S; Focke-Tejkl M; Bugajska-Schretter ; Ball T; Twardosz A; Spitzauer S; Grönlund H; Kraft D
Biol Chem; 1999; 380(7-8):815-24. PubMed ID: 10494830
[TBL] [Abstract][Full Text] [Related]
3. Strategies for converting allergens into hypoallergenic vaccine candidates.
Vrtala S; Focke-Tejkl M; Swoboda I; Kraft D; Valenta R
Methods; 2004 Mar; 32(3):313-20. PubMed ID: 14962766
[TBL] [Abstract][Full Text] [Related]
4. Molecular approaches for new vaccines against allergy.
Niederberger V; Valenta R
Expert Rev Vaccines; 2006 Feb; 5(1):103-10. PubMed ID: 16451112
[TBL] [Abstract][Full Text] [Related]
5. Recombinant allergens for diagnosis and therapy of allergic disease.
Chapman MD; Smith AM; Vailes LD; Arruda LK; Dhanaraj V; Pomés A
J Allergy Clin Immunol; 2000 Sep; 106(3):409-18. PubMed ID: 10984358
[TBL] [Abstract][Full Text] [Related]
6. Allergy diagnosis, allergen repertoires, and their implications for allergen-specific immunotherapy.
Crameri R
Immunol Allergy Clin North Am; 2006 May; 26(2):179-89, v. PubMed ID: 16701139
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic and therapeutic value of synthetic or recombinant allergens].
Spertini F
Rev Med Suisse Romande; 1999 Mar; 119(3):235-9. PubMed ID: 10218421
[TBL] [Abstract][Full Text] [Related]
8. Allergy testing: the role of recombinant allergens.
Mothes N; Valenta R; Spitzauer S
Clin Chem Lab Med; 2006; 44(2):125-32. PubMed ID: 16475895
[TBL] [Abstract][Full Text] [Related]
9. Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy.
Asturias JA; Ibarrola I; Arilla MC; Vidal C; Ferrer A; Gamboa PM; Viñuela JE; Sanz ML; Andreu C; Martínez A
Clin Exp Allergy; 2009 Jul; 39(7):1088-98. PubMed ID: 19400901
[TBL] [Abstract][Full Text] [Related]
10. Genetically modified allergens.
Niederberger V; Valenta R
Immunol Allergy Clin North Am; 2004 Nov; 24(4):727-38. PubMed ID: 15474868
[TBL] [Abstract][Full Text] [Related]
11. [Recombinant allergens: diagnostic use and therapeutic perspectives].
Pauli G; Deviller P
Rev Mal Respir; 2000 Feb; 17(1 Pt 2):293-303. PubMed ID: 10902143
[TBL] [Abstract][Full Text] [Related]
12. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
Focke M; Swoboda I; Marth K; Valenta R
Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812
[TBL] [Abstract][Full Text] [Related]
13. A hypoallergenic hybrid molecule with increased immunogenicity consisting of derivatives of the major grass pollen allergens, Phl p 2 and Phl p 6.
Linhart B; Mothes-Luksch N; Vrtala S; Kneidinger M; Valent P; Valenta R
Biol Chem; 2008 Jul; 389(7):925-33. PubMed ID: 18627317
[TBL] [Abstract][Full Text] [Related]
14. Biotechnology-based allergy diagnosis and vaccination.
Bhalla PL; Singh MB
Trends Biotechnol; 2008 Mar; 26(3):153-61. PubMed ID: 18222557
[TBL] [Abstract][Full Text] [Related]
15. Latex allergy: a model for therapy.
Rolland JM; O'Hehir RE
Clin Exp Allergy; 2008 Jun; 38(6):898-912. PubMed ID: 18498539
[TBL] [Abstract][Full Text] [Related]
16. Genetic allergen modification in the development of novel approaches to specific immunotherapy.
Mutschlechner S; Deifl S; Bohle B
Clin Exp Allergy; 2009 Nov; 39(11):1635-42. PubMed ID: 19624521
[TBL] [Abstract][Full Text] [Related]
17. Recombinant allergens for pollen immunotherapy.
Wallner M; Pichler U; Ferreira F
Immunotherapy; 2013 Dec; 5(12):1323-38. PubMed ID: 24283843
[TBL] [Abstract][Full Text] [Related]
18. Recombinant allergens for immunotherapy.
Valenta R; Niederberger V
J Allergy Clin Immunol; 2007 Apr; 119(4):826-30. PubMed ID: 17335886
[TBL] [Abstract][Full Text] [Related]
19. The future of antigen-specific immunotherapy of allergy.
Valenta R
Nat Rev Immunol; 2002 Jun; 2(6):446-53. PubMed ID: 12093011
[TBL] [Abstract][Full Text] [Related]
20. Successful replacement of allergen-specific immunotherapy by allergen-mixture therapy.
Song CH; Heiner DC
Ann Allergy Asthma Immunol; 1995 Nov; 75(5):402-8. PubMed ID: 7583861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
